Grufity logo
Grufity logo
NMRD

NMRD - Nemaura Medical Inc Stock Price, Fair Value and News

00
Market Closed as of 15 Jun 2026, 04:00 pm ET

Price Targets

NMRD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NMRD Price Action

NMRD RSI Chart

NMRD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NMRD Valuation

Market Cap

0

Price/Earnings (Trailing)

0

Price/Sales (Trailing)

0

EV/EBITDA

-1.01

Price/Free Cashflow

0

NMRD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

NMRD Fundamentals

NMRD Revenue

NMRD Earnings

NMRD Profitability

Free Cashflow Yield

0%

NMRD Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
202377.0K---
2022503.9K-361.6K219.3K
2021----
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Nemaura Medical Inc

NMRD
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
 CEO
 WEBSITEhttps://nemauramedical.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES36

Nemaura Medical Inc Frequently Asked Questions

NMRD is the stock ticker symbol of Nemaura Medical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu May 28 2026, market cap of Nemaura Medical Inc is 0. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Thu May 28 2026, NMRD's PE ratio (Price to Earnings) is 0 and Price to Sales (PS) ratio is 0. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NMRD PE ratio will change depending on the future growth rate expectations of investors.